Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14675098rdf:typepubmed:Citationlld:pubmed
pubmed-article:14675098lifeskim:mentionsumls-concept:C0030190lld:lifeskim
pubmed-article:14675098lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:14675098lifeskim:mentionsumls-concept:C0483249lld:lifeskim
pubmed-article:14675098lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:14675098lifeskim:mentionsumls-concept:C0040044lld:lifeskim
pubmed-article:14675098pubmed:issue12lld:pubmed
pubmed-article:14675098pubmed:dateCreated2003-12-16lld:pubmed
pubmed-article:14675098pubmed:abstractTextSeveral activated coagulation factors have been reported to enhance fibrinolysis by neutralizing plasminogen activator inhibitor type 1 (PAI-1) activity. We evaluated the physiological relevance of this mechanism using the euglobulin clot lysis time (ECLT) assay in the presence and absence of Ca2+, which is controlled by PAI-1 and mimics physiological thrombolysis. We found that the ECLT (18.5 +/- 0.6 h) was shortened by Ca2+ (5 mm) (6.6 +/- 0.1 h). A significant difference was observed in thrombin generation by the presence of Ca2+ in the euglobulin fraction. Prothrombin was almost fully converted to thrombin within 15 min in the presence of Ca2+, whereas essentially no conversion was observed without Ca2+. The presence of activated protein C (aPC) suppressed thrombin generation, and attenuated the shortening of ECLT in a dose-dependent manner, an effect enhanced by phospholipid and protein S. In the absence of Ca2+, aPC did not prolong the ECLT. After addition of biotin-labeled recombinant PAI-1 to the euglobulin fraction, PAI-1 was cleaved to lower molecular weight forms only in the presence of Ca2+. This cleavage did not occur in the presence of aPC, suggesting that thrombin was the catalyst for PAI-1 cleavage. The cleavage and inactivation of PAI-1 by generated thrombin is proposed to be responsible for the shortening of ECLT by Ca2+ and for coagulation-associated over-expression of fibrinolysis. Under such conditions, aPC appeared to suppress thrombin generation and to normalize highly activated fibrinolysis.lld:pubmed
pubmed-article:14675098pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:languageenglld:pubmed
pubmed-article:14675098pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:citationSubsetIMlld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14675098pubmed:statusMEDLINElld:pubmed
pubmed-article:14675098pubmed:monthDeclld:pubmed
pubmed-article:14675098pubmed:issn1538-7933lld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:SuzukiYYlld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:CastellinoF...lld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:SuzukiKKlld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:OhtaMMlld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:MogamiHHlld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:UranoTTlld:pubmed
pubmed-article:14675098pubmed:authorpubmed-author:IharaHHlld:pubmed
pubmed-article:14675098pubmed:issnTypePrintlld:pubmed
pubmed-article:14675098pubmed:volume1lld:pubmed
pubmed-article:14675098pubmed:ownerNLMlld:pubmed
pubmed-article:14675098pubmed:authorsCompleteYlld:pubmed
pubmed-article:14675098pubmed:pagination2615-20lld:pubmed
pubmed-article:14675098pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:meshHeadingpubmed-meshheading:14675098...lld:pubmed
pubmed-article:14675098pubmed:year2003lld:pubmed
pubmed-article:14675098pubmed:articleTitleActivated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1.lld:pubmed
pubmed-article:14675098pubmed:affiliationDepartment of Physiology, Hamamatsu University School of Medicine, Handa-yama, Hamamatsu, Japan. uranot@hama-med.ac.jplld:pubmed
pubmed-article:14675098pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14675098pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:14675098pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5054entrezgene:pubmedpubmed-article:14675098lld:entrezgene
entrez-gene:5624entrezgene:pubmedpubmed-article:14675098lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:14675098lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:14675098lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14675098lld:pubmed